White label – Pompe disease - ClinicalTrials.eu

Study Comparing Acalabrutinib to Standard Treatments for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia refractory
Investigated Drugs:
- Acalabrutinib
Study on the Effects of Bosentan for Patients with Early Stage Non-Arteritic Anterior Ischemic Optic Neuropathy

Not recruiting

3 1 1 1
Investigated Diseases:
- Optic ischaemic neuropathy
Investigated Drugs:
- Bosentan
Study of Osilodrostat for Children and Adolescents with Cushing’s Disease

Not recruiting

2 1 1 1
Investigated Diseases:
- Pituitary-dependent Cushing’s syndrome
Investigated Drugs:
- Osilodrostat
Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting

3 1 1 1
Investigated Drugs:
Study to Determine Safe and Effective Dose of Daridorexant for Treating Insomnia in Children and Adolescents Aged 10 to 18 Years

Not recruiting

2 1 1
Investigated Diseases:
- Insomnia
Investigated Drugs:
- Daridorexant
Study of RO7121661, RO7247669, and Nivolumab for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Not recruiting

2 1 1
Study on WT1 mRNA DC Vaccine to Prevent Relapse in Adults with Acute Myeloid Leukemia

Not recruiting

2 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Wt1 Mrna Dc
Study of Encorafenib and Binimetinib for Patients with BRAFV600E-Mutant Metastatic Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage IV
Investigated Drugs:
- Binimetinib
- Encorafenib
Study Comparing Tacrolimus Formulations for Preventing Liver Transplant Rejection in New Adult Recipients

Not recruiting

3 1 1 1
Investigated Drugs:
- Tacrolimus
Study of Dabrafenib and Drug Combination for Patients with Metastatic Non-Clear Cell Kidney Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Renal cell carcinoma
- Clear cell renal cell carcinoma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies